1. Home
  2. Publications & Reports
  3. Policy Directives & Guidelines
  4. Influenza - Use of Intravenous Peramivir in Influenza Patients
Print this page Reduce font size Increase font size

Influenza - Use of Intravenous Peramivir in Influenza Patients

Doc type: Policy Directive
Compliance with this policy directive is mandatory.

Doc No.: PD2010_012

Functional Group - Sub Group:
Clinical/ Patient Services - Critical care
Clinical/ Patient Services - Pharmaceutical
Population Health - Communicable Diseases

Summary
This Policy Directive authorises a treating physician in consultation with an infectious diseases physician to obtain the unlicenced medication peramivir injection for the treatment of severe influenza in intensive care patients who fulfil the eligibility criteria.

Date of Publication: 10 February 2010

Replaces: N/A
Author Branch: Communicable Diseases

This document applies to: Area Health Services/Chief Executive Governed Statutory Health Corporation, Board Governed Statutory Health Corporations, Affiliated Health Organisations - Non Declared, Affiliated Health Organisations - Declared, Public Health System Support Division, Government Medical Officers, Public Health Units, Public Hospitals

Audience: Critical Care, Pharmaceutical

Distributed to: Public Health System, Government Medical Officers, NSW Department of Health

Review Date: 10 February 2015

Policy Manual: Patient Matters

File No: 09/2926-3

Status: Active

File link: Influenza - Use of Intravenous Peramivir in Influenza Patients
File size: 73Kb

Influenza - Use of Intravenous Peramivir in Influenza Patients

Print this page Reduce font size Increase font size